Arrowhead Pharmaceuticals Inc. buy B. Riley
Start price
14.02.25
/
50%
€18.85
Target price
14.02.26
€36.16
Performance (%)
-26.68%
Price
17:51
€13.82
Summary
This prediction is currently active. The prediction for Arrowhead Pharmaceuticals Inc. disappoints with a performance of -26.68%. This prediction currently runs until 14.02.26. The prediction end date can be changed by B__Riley at any time. B__Riley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Arrowhead Pharmaceuticals Inc. | 11.049% | 11.049% |
| iShares Core DAX® | -1.165% | -0.351% |
| iShares Nasdaq 100 | 1.585% | 4.605% |
| iShares Nikkei 225® | 1.992% | -2.018% |
| iShares S&P 500 | 2.158% | 4.638% |
Comments by B__Riley for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $38.00 price target on the stock, down previously from $51.00.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by B__Riley for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€21.28
12.08.24
12.08.24
€50.31
12.08.25
12.08.25
-32.17%
17:51
17:51
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€31.22
20.07.23
20.07.23
€49.32
20.07.24
20.07.24
-17.26%
21.07.24
21.07.24